Although the elevated expression of GLS1 in the stromal cell compartments has been recognized for thyroid and breast cancers [233,234], the elevation in GTK and ω-amidase in the stromal cell compartments has, thus far, only been identified within prostatic cancer [1]. The gene discussed is GLS; the disease is prostate cancer.